Stock BTG BERONI GROUP LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Company Beroni Group Limited

Equities

BTG

AU000000BTG8

Pharmaceuticals

End-of-day quote National Stock Exchange of Australia
Other stock markets
 06:00:00 2022-09-22 pm EDT 		5-day change 1st Jan Change
3.96 AUD -20.80% Intraday chart for Beroni Group Limited -.--% -.--%
Mar. 15 Beroni Group Limited Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 Beroni Group Limited Reports Earnings Results for the Half Year Ended June 30, 2023 CI

Business Summary

Beroni Group Limited is an Australia-based international biopharmaceutical company. The Company is engaged in the commercialization of drugs and therapies to combat various global diseases such as cancer and infectious diseases. It is engaged in the sales of smoking control product (NicoBloc), air purifier, water filter, healthcare products and supplements, cell therapies, stem-cell based cosmetics and viral diagnostic kits and also investing in the research and development of oncology drugs and therapies. Its diversified portfolio is comprised of virus diagnostic kits, an e-commerce platform for the sale of pharmaceutical products and a development pipeline targeting oncology and cell therapies. It operates in Australia, United States, China and Japan. Its products offering include NicoBloc, CII-ArboViroPlex rRT-PCR assay and stem cell cosmetic products, including AGG Skin-Smoothing and Anti-Wrinkle Facial Mask, ODd Skin Repair Essence, ODd Beroni Beauty Facial Mask, and others.

Sales per Business

AUD in Million2020Weight2021Weight Delta
Viral Diagnostic kits
43.5 %
0 8.4 % 1 43.5 % +533.46%
Health Supplements
20.9 %
0 16.0 % 0 20.9 % +59.73%
Cosmetic Products
17.4 %
1 45.6 % 0 17.4 % -53.13%
All Other
11.2 %
0 3.3 % 0 11.2 % +312.89%
Nicobloc
6.9 %
0 26.5 % 0 6.9 % -68.27%
Olansi Water Filter
0.1 %
0 0.1 % 0 0.1 % -11.80%

Sales per region

AUD in Million2020Weight2021Weight Delta
China
100.0 %
2 99.6 % 2 100.0 % +23.00%

Managers

Managers TitleAgeSince
Bo Qing Zhang CEO
 Chief Executive Officer 55 16-06-16
Yap Ting Wong DFI
 Director of Finance/CFO 62 16-09-29
Chen Chik Ong BRD
 Director/Board Member 45 -

Members of the board

Members of the board TitleAgeSince
Chen Chik Ong BRD
 Director/Board Member 45 -
John Chiplin BRD
 Director/Board Member 66 22-03-31
Richard Buchta BRD
 Director/Board Member 66 20-06-30
Yap Ting Wong DFI
 Director of Finance/CFO 62 16-09-29
Bo Qing Zhang CEO
 Chief Executive Officer 55 16-06-16
Hai Huang FOU
 Founder 57 16-06-16
Li Bing Guo BRD
 Director/Board Member 53 16-11-02
Zhi Nan Yin BRD
 Director/Board Member 59 18-06-30

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 17,525,587 17,350,331 ( 99.00 %) 0 99.00 %

Company contact information

Beroni Group Ltd.

175 Pitt Street Level 16

2000, Sydney

+61 2 9159 1827

http://www.beronigroup.com
address Beroni Group Limited(BTG)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Sector Other Pharmaceuticals

1st Jan change Capi.
BERONI GROUP LIMITED Stock Beroni Group Limited
-.--% 51.99M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+33.25% 704B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+28.59% 577B
JOHNSON & JOHNSON Stock Johnson & Johnson
-3.55% 348B
MERCK & CO., INC. Stock Merck & Co., Inc.
+18.16% 327B
ABBVIE INC. Stock AbbVie Inc.
+4.36% 288B
ASTRAZENECA PLC Stock AstraZeneca PLC
+14.81% 234B
NOVARTIS AG Stock Novartis AG
+4.93% 198B
ROCHE HOLDING AG Stock Roche Holding AG
-9.78% 194B
AMGEN INC. Stock Amgen Inc.
-3.69% 147B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. BTG Stock
  4. Company Beroni Group Limited